After the 28-day window closes, any remaining medication should be discarded safely, even if it appears clear and colorless
BMI and Health History Typically, candidates for prescription weight loss programs have a Body Mass Index (BMI) of 30 or greater, or a BMI of 27 or greater with at least one weight-related condition, such as high blood pressure or high cholesterol
Sinha R, Rapamargaritis D, Sargeant JA, Davies MJ (2023) Efficacy and safety of tirzepatide in type 2 diabetes and obesity management
However, preliminary investigations and user reports suggest possible outcomes
Barrier disruption, in turn, makes bile acids and their harmful metabolites more likely to enter the systemic circulation, thereby activating metabolic and inflammation pathways in the liver and other distal organs, and promoting the progression of NAFLD/non-alcoholic steatohepatitis (NASH) and metabolic diseases, highlighting the impact of bile acids in systemic diseases (Fleishman and Kumar, 2024)
The most common adverse events were gastrointestinal